ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
Blinger
|
1.0K |
423K |
0 |
14/06/24 |
14/06/24 |
ASX - By Stock
|
1.0K
|
423K
|
0
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Investor Presentation
|
|
Blinger
|
609 |
105K |
2 |
14/06/24 |
14/06/24 |
ASX - By Stock
|
609
|
105K
|
2
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Investor Presentation
|
|
Blinger
|
609 |
105K |
8 |
14/06/24 |
14/06/24 |
ASX - By Stock
|
609
|
105K
|
8
|
|
ASX - By Stock
|
BUX |
Re:
Ann: Buxton Investor Presentation
|
|
Blinger
|
58 |
19K |
7 |
14/06/24 |
14/06/24 |
ASX - By Stock
|
58
|
19K
|
7
|
|
Charts
|
IMU Biotech |
Re:
IMUGENE CHART. TA only
|
|
Blinger
|
33K |
16M |
1 |
13/06/24 |
13/06/24 |
Charts
|
33K
|
16M
|
1
|
|
Charts
|
IMU Biotech |
Re:
IMUGENE CHART. TA only
|
|
Blinger
|
33K |
16M |
1 |
13/06/24 |
13/06/24 |
Charts
|
33K
|
16M
|
1
|
|
Charts
|
IMU Biotech |
Re:
IMUGENE CHART. TA only
|
|
Blinger
|
33K |
16M |
2 |
13/06/24 |
13/06/24 |
Charts
|
33K
|
16M
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
Blinger
|
1.0K |
423K |
0 |
13/06/24 |
13/06/24 |
ASX - By Stock
|
1.0K
|
423K
|
0
|
|
Charts
|
IMU Biotech |
Re:
IMUGENE CHART. TA only
|
|
Blinger
|
33K |
16M |
1 |
13/06/24 |
13/06/24 |
Charts
|
33K
|
16M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
Blinger
|
1.0K |
423K |
0 |
13/06/24 |
13/06/24 |
ASX - By Stock
|
1.0K
|
423K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
Blinger
|
1.0K |
423K |
0 |
13/06/24 |
13/06/24 |
ASX - By Stock
|
1.0K
|
423K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
Blinger
|
1.0K |
423K |
0 |
13/06/24 |
13/06/24 |
ASX - By Stock
|
1.0K
|
423K
|
0
|
|
Charts
|
IMU Biotech |
Re:
IMUGENE CHART. TA only
|
|
Blinger
|
33K |
16M |
0 |
13/06/24 |
13/06/24 |
Charts
|
33K
|
16M
|
0
|
|
Charts
|
IMU Biotech |
Re:
IMUGENE CHART. TA only
|
|
Blinger
|
33K |
16M |
0 |
13/06/24 |
13/06/24 |
Charts
|
33K
|
16M
|
0
|
|
Charts
|
IMU Biotech |
Re:
IMUGENE CHART. TA only
|
|
Blinger
|
33K |
16M |
2 |
13/06/24 |
13/06/24 |
Charts
|
33K
|
16M
|
2
|
|
ASX - By Stock
|
TVN |
Re:
住友商事株式会社 - Sumitomo Shoji Kabushiki Geisha
|
|
Blinger
|
86 |
31K |
1 |
13/06/24 |
13/06/24 |
ASX - By Stock
|
86
|
31K
|
1
|
|
ASX - By Stock
|
TVN |
Re:
住友商事株式会社 - Sumitomo Shoji Kabushiki Geisha
|
|
Blinger
|
86 |
31K |
1 |
13/06/24 |
13/06/24 |
ASX - By Stock
|
86
|
31K
|
1
|
|
ASX - By Stock
|
TVN |
Re:
住友商事株式会社 - Sumitomo Shoji Kabushiki Geisha
|
|
Blinger
|
86 |
31K |
1 |
13/06/24 |
13/06/24 |
ASX - By Stock
|
86
|
31K
|
1
|
|
ASX - By Stock
|
TVN |
Re:
住友商事株式会社 - Sumitomo Shoji Kabushiki Geisha
|
|
Blinger
|
86 |
31K |
1 |
13/06/24 |
13/06/24 |
ASX - By Stock
|
86
|
31K
|
1
|
|
ASX - By Stock
|
TVN |
Re:
住友商事株式会社 - Sumitomo Shoji Kabushiki Geisha
|
|
Blinger
|
86 |
31K |
2 |
13/06/24 |
13/06/24 |
ASX - By Stock
|
86
|
31K
|
2
|
|
ASX - By Stock
|
TVN |
Re:
住友商事株式会社 - Sumitomo Shoji Kabushiki Geisha
|
|
Blinger
|
86 |
31K |
1 |
13/06/24 |
13/06/24 |
ASX - By Stock
|
86
|
31K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
Blinger
|
1.0K |
423K |
0 |
13/06/24 |
13/06/24 |
ASX - By Stock
|
1.0K
|
423K
|
0
|
|
Charts
|
IMU Biotech |
Re:
IMUGENE CHART. TA only
|
|
Blinger
|
33K |
16M |
7 |
13/06/24 |
13/06/24 |
Charts
|
33K
|
16M
|
7
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Investor Presentation
|
|
Blinger
|
609 |
105K |
4 |
13/06/24 |
13/06/24 |
ASX - By Stock
|
609
|
105K
|
4
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Investor Presentation
|
|
Blinger
|
609 |
105K |
7 |
12/06/24 |
12/06/24 |
ASX - By Stock
|
609
|
105K
|
7
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Investor Presentation
|
|
Blinger
|
609 |
105K |
3 |
11/06/24 |
11/06/24 |
ASX - By Stock
|
609
|
105K
|
3
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Investor Presentation
|
|
Blinger
|
609 |
105K |
5 |
11/06/24 |
11/06/24 |
ASX - By Stock
|
609
|
105K
|
5
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Investor Presentation
|
|
Blinger
|
609 |
105K |
7 |
11/06/24 |
11/06/24 |
ASX - By Stock
|
609
|
105K
|
7
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Investor Presentation
|
|
Blinger
|
609 |
105K |
8 |
11/06/24 |
11/06/24 |
ASX - By Stock
|
609
|
105K
|
8
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Investor Presentation
|
|
Blinger
|
609 |
105K |
5 |
10/06/24 |
10/06/24 |
ASX - By Stock
|
609
|
105K
|
5
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Investor Presentation
|
|
Blinger
|
609 |
105K |
7 |
10/06/24 |
10/06/24 |
ASX - By Stock
|
609
|
105K
|
7
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Investor Presentation
|
|
Blinger
|
609 |
105K |
2 |
10/06/24 |
10/06/24 |
ASX - By Stock
|
609
|
105K
|
2
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Investor Presentation
|
|
Blinger
|
609 |
105K |
4 |
09/06/24 |
09/06/24 |
ASX - By Stock
|
609
|
105K
|
4
|
|
ASX - By Stock
|
DXB |
Re:
DXB - Research & Valuation
|
|
Blinger
|
230 |
105K |
0 |
09/06/24 |
09/06/24 |
ASX - By Stock
|
230
|
105K
|
0
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Investor Presentation
|
|
Blinger
|
609 |
105K |
2 |
09/06/24 |
09/06/24 |
ASX - By Stock
|
609
|
105K
|
2
|
|
ASX - By Stock
|
DXB |
Re:
DXB - Research & Valuation
|
|
Blinger
|
230 |
105K |
0 |
09/06/24 |
09/06/24 |
ASX - By Stock
|
230
|
105K
|
0
|
|
ASX - By Stock
|
DXB |
Re:
DXB - Research & Valuation
|
|
Blinger
|
230 |
105K |
4 |
09/06/24 |
09/06/24 |
ASX - By Stock
|
230
|
105K
|
4
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Investor Presentation
|
|
Blinger
|
609 |
105K |
4 |
09/06/24 |
09/06/24 |
ASX - By Stock
|
609
|
105K
|
4
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Investor Presentation
|
|
Blinger
|
609 |
105K |
2 |
08/06/24 |
08/06/24 |
ASX - By Stock
|
609
|
105K
|
2
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Investor Presentation
|
|
Blinger
|
609 |
105K |
3 |
08/06/24 |
08/06/24 |
ASX - By Stock
|
609
|
105K
|
3
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Investor Presentation
|
|
Blinger
|
609 |
105K |
2 |
08/06/24 |
08/06/24 |
ASX - By Stock
|
609
|
105K
|
2
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Investor Presentation
|
|
Blinger
|
609 |
105K |
2 |
08/06/24 |
08/06/24 |
ASX - By Stock
|
609
|
105K
|
2
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Investor Presentation
|
|
Blinger
|
609 |
105K |
2 |
08/06/24 |
08/06/24 |
ASX - By Stock
|
609
|
105K
|
2
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Investor Presentation
|
|
Blinger
|
609 |
105K |
2 |
08/06/24 |
08/06/24 |
ASX - By Stock
|
609
|
105K
|
2
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Investor Presentation
|
|
Blinger
|
609 |
105K |
3 |
08/06/24 |
08/06/24 |
ASX - By Stock
|
609
|
105K
|
3
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Investor Presentation
|
|
Blinger
|
609 |
105K |
5 |
08/06/24 |
08/06/24 |
ASX - By Stock
|
609
|
105K
|
5
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Investor Presentation
|
|
Blinger
|
609 |
105K |
9 |
08/06/24 |
08/06/24 |
ASX - By Stock
|
609
|
105K
|
9
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Investor Presentation
|
|
Blinger
|
609 |
105K |
9 |
07/06/24 |
07/06/24 |
ASX - By Stock
|
609
|
105K
|
9
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Investor Presentation
|
|
Blinger
|
609 |
105K |
6 |
07/06/24 |
07/06/24 |
ASX - By Stock
|
609
|
105K
|
6
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Investor Presentation
|
|
Blinger
|
609 |
105K |
10 |
07/06/24 |
07/06/24 |
ASX - By Stock
|
609
|
105K
|
10
|
|